{"transactions":[{"id":4587176,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":181876,"kind":"organization","name":"Xi Long USA, Inc.","position":1,"cik":"0001684591","reported_name":"Xi Long USA, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Predecessor Class D-2 Preferred Units","published_at":"2016-10-04T18:07:08.000Z","date":"2016-09-30","kind":"other","acquired":false,"shares":15394737,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-2 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Prior to the Reorganization, the Predecessor's Class D-2 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with a qualified initial public offering of the Predecessor or a successor thereof."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The securities were disposed of and cancelled in the Reorganization, a transaction exempt under Rule 16b-7 under the Exchange Act, in exchange for 2,025,623 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The securities were disposed of and cancelled in the Reorganization, a transaction exempt under Rule 16b-7 under the Exchange Act, in exchange for 2,025,623 shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Prior to the Reorganization, the Predecessor's Class D-2 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with a qualified initial public offering of the Predecessor or a successor thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Prior to the Reorganization, the Predecessor's Class D-2 preferred units had no expiration date and were convertible into the Predecessor's Class D voting common units, on a one-for-one basis and for no additional consideration, at any time at the option of the holder and in connection with a qualified initial public offering of the Predecessor or a successor thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Reflects securities of the Predecessor. Fulgent LLC is considered the predecessor of the Issuer following completion of a reorganization transaction pursuant to which the Predecessor became a wholly owned subsidiary of the Issuer (the \"Reorganization\"), which was completed on September 30, 2016 in connection with the Issuer's initial public offering and which is described in the Issuer's Registration Statement on Form S-1, as amended (File No. 333-213469). In the Reorganization, all of the Predecessor's Class D-2 preferred units were cancelled in exchange for shares of the Issuer's common stock at a ratio of 7.6-for-1."}],"balance_after":0,"derivative":{"underlying":"Predecessor Class D Voting Common Units","underlying_shares":15394737},"source":{"system":"sec-edgar","filing":"0001209191-16-144640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684591/000120919116144640/doc4.xml","form_type":"4"}},{"id":4587175,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":181876,"kind":"organization","name":"Xi Long USA, Inc.","position":1,"cik":"0001684591","reported_name":"Xi Long USA, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Issuer Common Stock","published_at":"2016-10-04T18:07:08.000Z","date":"2016-09-30","kind":"other","acquired":true,"shares":2025623,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were received in the Reorganization (as defined below), a transaction exempt under Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), in exchange for the cancellation of 15,394,737 Class D-2 preferred units of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were received in the Reorganization (as defined below), a transaction exempt under Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), in exchange for the cancellation of 15,394,737 Class D-2 preferred units of Fulgent Therapeutics LLC (the \"Predecessor\" or \"Fulgent LLC\")."}],"balance_after":2025623,"source":{"system":"sec-edgar","filing":"0001209191-16-144640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684591/000120919116144640/doc4.xml","form_type":"4"}}]}